Yeh Shiou-Hwei is a distinguished professor of the College of Medicine, Graduate Institute of Microbiology at National Taiwan University. She proved that men are more susceptible to liver cancer and discovered and confirmed that the targeted drug therapy for liver cancer, Sorafenib and its chemical derivatives, through the liver-specific protein molecule (SHP1), specifically inhibit the hepatic androgen signal transmission pathway, without affecting the male reproductive system. Therefore, it can reduce the occurrence of male liver cancer, but still retain the function of normal male fertility.